Understanding the impact of painful diabetic neuropathy
- 1 January 2003
- journal article
- review article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 19 (S1) , S2-S8
- https://doi.org/10.1002/dmrr.360
Abstract
Painful neuropathy is a common and often distressing complication of diabetes. It has considerable impact on the social and psychological well-being of affected individuals. There are two distinct forms of painful neuropathy: an acute and self-limiting form that resolves within a year or a chronic form that can go on for years. There are now a number of drugs available for the treatment of neuropathic pain. However, some may fail to respond to these drugs or may have unacceptable adverse side effects. When this is the case, the patient's quality of life can be severely affected. Health care professionals need to assess the full impact of painful neuropathy. In this article we review a number of instruments that are used to assess the severity of painful neuropathy and its impact on the quality of life.Keywords
This publication has 49 references indexed in Scilit:
- The Natural Progression of Autonomic Neuropathy and Autonomic Function Tests in a Cohort of People With IDDMDiabetes Care, 1996
- Diabetic Oculomotor Mononeuropathy: Involvement of Pupillomotor Fibres with Slow ResolutionHormone and Metabolic Research, 1990
- Employment Problems and DiabetesDiabetic Medicine, 1990
- Glucose Intolerance and Hypertension in North London: The Islington Diabetes SurveyDiabetic Medicine, 1986
- Peripheral Arterial Thrombosis Due to the Nephrotic SyndromeSouthern Medical Journal, 1983
- FOCAL NEUROLOGICAL SYMPTOMS ASSOCIATED WITH UNCONTROLLED DIABETESThe Lancet, 1978
- Diabetic Truncal Mononeuropathy — A New Clinical SyndromeDiabetes Care, 1978
- The McGill Pain Questionnaire: Major properties and scoring methodsPain, 1975
- Diabetic Amyotrophy: A Follow-up StudyBMJ, 1972